US 8614198
Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use
granted A61PA61P31/14
Quick answer
US patent 8614198 (Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use) held by Alnylam Pharmaceuticals, Inc. expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P31/14